Back
Esperion Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
26
ESPR
Esperion Therapeutics
Last Price:
$0.92
Seasonality Move:
-1.39%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and ESPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Esperion Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.93 | Sell |
| 20-day SMA: | 1.1 | Sell |
| 50-day SMA: | 1.45 | Sell |
| 200-day SMA: | 1.98 | Sell |
| 8-day EMA: | 0.94 | Sell |
| 20-day EMA: | 0.97 | Sell |
| 50-day EMA: | 0.74 | Buy |
| 200-day EMA: | 0.28 | Buy |
Esperion Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 30.98 | Sell |
| Chaikin Money Flow: | 2736515 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.92 - 1.5) | Sell |
| Bollinger Bands (100): | (1.29 - 2.51) | Sell |
Esperion Therapeutics Technical Analysis
| Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Esperion Therapeutics Stock
Is Esperion Therapeutics Stock a Buy?
-
Esperion Therapeutics share price is 0.92 while ESPR 8-day simple moving average is 0.93, which is a Sell signal.
-
The stock price of ESPR is 0.92 while Esperion Therapeutics 20-day SMA is 1.10, which makes it a Sell.
-
Esperion Therapeutics 50-day simple moving average is 1.45 while ESPR share price is 0.92, making it a Sell technically.
-
ESPR stock price is 0.92 and Esperion Therapeutics 200-day simple moving average is 1.98, creating a Sell signal.
ESPR Technical Analysis vs Fundamental Analysis
Sell
26
Esperion Therapeutics (ESPR)
is a Sell
Is Esperion Therapeutics a Buy or a Sell?
-
Esperion Therapeutics stock is rated a SellThe current Esperion Therapeutics [ESPR] share price is $0.92. The Score for ESPR is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
Esperion Therapeutics Stock Info
Market Cap:
182M
Price in USD:
0.92
Share Volume:
4.8M
Esperion Therapeutics 52-Week Range
52-Week High:
3.94
52-Week Low:
0.82
Sell
26
Esperion Therapeutics (ESPR)
is a Sell
Esperion Therapeutics Share Price Forecast
-
What is the Esperion Therapeutics stock price today?The Esperion Therapeutics stock price is 0.92 USD today.
-
Will ESPR stock go up or go down?Esperion Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Esperion Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Esperion Therapeutics is overvalued.
Is Esperion Therapeutics Stock a Buy?
-
Esperion Therapeutics share price is 0.92 while ESPR 8-day exponential moving average is 0.94, which is a Sell signal.
-
The stock price of ESPR is 0.92 while Esperion Therapeutics 20-day EMA is 0.97, which makes it a Sell.
-
Esperion Therapeutics 50-day exponential moving average is 0.74 while ESPR share price is 0.92, making it a Buy technically.
-
ESPR stock price is 0.92 and Esperion Therapeutics 200-day simple moving average is 0.28, creating a Buy signal.
Fundamental Analysis of Esperion Therapeutics
Is Esperion Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.23 per share, and a decrease next year of $0.38 per share.
Technical Analysis of Esperion Therapeutics
Should I short Esperion Therapeutics stock?
-
ESPR Moving Average Covergence Divergence (MACD) indicator is 0.03, suggesting Esperion Therapeutics is a Buy
-
Esperion Therapeutics Relative Strength Index (RSI) is 30.98, which suggest Esperion Therapeutics is oversold
-
The Bollinger Bands (25) for Esperion Therapeutics is (0.92 - 1.5), which suggest Esperion Therapeutics is a Sell
-
The Bollinger Bands (100) for Esperion Therapeutics is (1.29 - 2.51), which suggest Esperion Therapeutics is a Sell
* Esperion Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.